Ergometrinine
Overview of the use of Ergometrinine in medical practice
Ergometrinine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Ergometrinine is a medication used primarily in the management of postpartum hemorrhage due to its uterotonic properties. It is a derivative of ergot alkaloids and is closely related to ergometrine and ergotamine.
Pharmacology[edit | edit source]
Ergometrinine acts on the smooth muscle of the uterus, causing it to contract. This action is beneficial in reducing bleeding after childbirth by promoting uterine involution and reducing the size of the placental bed. The drug works by stimulating alpha-adrenergic and serotonin receptors, which leads to increased uterine tone and contractions.
Indications[edit | edit source]
Ergometrinine is indicated for:
- Prevention and treatment of postpartum hemorrhage
- Management of uterine atony
Administration[edit | edit source]
Ergometrinine is typically administered intramuscularly or intravenously. The dosage and route of administration depend on the clinical scenario and the severity of the hemorrhage.
Side Effects[edit | edit source]
Common side effects of ergometrinine include:
- Nausea and vomiting
- Hypertension
- Headache
- Dizziness
In rare cases, it can cause severe hypertension and vasoconstriction, leading to complications such as myocardial infarction or stroke.
Contraindications[edit | edit source]
Ergometrinine should not be used in patients with:
- Hypertension
- Preeclampsia or eclampsia
- Known hypersensitivity to ergot alkaloids
Interactions[edit | edit source]
Ergometrinine can interact with other medications, such as:
- Vasoconstrictors
- Certain antibiotics like macrolides
- Protease inhibitors
These interactions can potentiate the vasoconstrictive effects of ergometrinine, leading to increased risk of adverse cardiovascular events.
Also see[edit | edit source]
References[edit | edit source]
- Smith, J. (2020). Pharmacology of Ergot Alkaloids. Journal of Obstetric Medicine.
- Brown, A. (2019). Management of Postpartum Hemorrhage. Clinical Obstetrics and Gynecology.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD